ACRF International Centre for the Proteome of Human Cancer

  • Research Institute: Children’s Medical Research Institute

  • Amount granted: $10 million

  • Year granted: 2015

The Australian Cancer Research Foundation awarded one of the largest private grants for medical research equipment in Australian history – $10 million – for six cutting-edge machines to establish The ACRF International Centre for the Proteome of Cancer (ProCanTM) at Children’s Medical Research Institute (CMRI) in Westmead. The Centre was officially opened in September 2016.

Over the next five years, scientists at CMRI will analyse tens of thousands of examples of all types of cancer from all over the world to develop a library of information to advance scientific discovery and enhance clinical treatment worldwide.

ProCan will provide a major step forward for cancer diagnosis and treatment of Australians and the end result will be rapid and more accurate prediction of the best cancer treatments for each individual patient.

The Centre will be led by CMRI Professors Phil Robinson and Roger Reddel in partnership with technology experts, such as Professor Ruedi Aebersold. New technology called PCT-SWATH mass spectrometry will be used to rapidly and simultaneously measure the precise levels of many thousands of proteins in very small cancer biopsies. Working with leading cancer researchers throughout Australia and around the world, the Centre will analyse about 70,000 samples of all types of cancer, including leukaemia.

Project highlights to date

  • Agreement signed with SCIEX in February 2016, ProCan designated as a “SCIEX Centre of Innovation in Precision Medicine”
  • The project became part of the ‘Cancer Moonshot’ initiative led by the United States’ Government in July 2016
  • Official opening of ProCan in September 2016
  • Procan.cancerresearch website launched in September 2016
  • What your donations have achieved

    Cervical cancer vaccine

    We gave initial seed funding to Professor Ian Frazer’s research into the cervical cancer (HPV). Over 150 million doses of vaccine have been delivered worldwide to date.

    Help fund cancer research
  • What your donations have achieved

    The pill that melts away cancer

    Our long term support of cancer research at WEHI has led to a treatment that melts away certain advanced forms of chronic lymphocytic leukaemia. It has been approved for clinical use in the US, European Union and Australia and is being trialed for other types of cancer.

    Help fund cancer research
  • What your donations have achieved

    Personalised cancer diagnosis

    In 2015, we awarded $10 million seed funding to an ambitious cancer proteome project that aims to provide each cancer patient a personalised treatment plan within 36 hours. This will improve treatment outcomes and help avoid unnecessary treatments.

    Help fund cancer research
  • What your donations have achieved

    Zero childhood cancer

    We are one of the founding partners of the initiative that will tackle the most serious cases of infant, childhood and adolescent cancer in Australia. It is a key step towards the program vision of one day helping to cure 100% of children with cancer.

    Help fund cancer research